Lv1
80 积分 2021-07-26 加入
Nonalcoholic fatty liver disease in Asia: emerging perspectives
3天前
已完结
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
10天前
已完结
Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial
10天前
已完结
TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability
16天前
已关闭
TRIB3–TRIM8 complex drives NAFLD progression by regulating HNF4α stability
17天前
已完结
Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis
22天前
已完结
Changes of flavin-containing monooxygenases and trimethylamine-N-oxide may be involved in the promotion of non-alcoholic fatty liver disease by intestinal microbiota metabolite trimethylamine
22天前
已完结
Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
22天前
已完结
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
22天前
已完结
Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice
24天前
已完结
皖公网安备34019202002308
